Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial

Faster, Cleaner, Better.

Avalon Globocare (ALBT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Cash Flow for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2025	09-2025	06-2025	03-2025	12-2024
Cash Flows From Operating Activities
Net Income	-17,519	-16,195	-15,941	-2,482	-7,040
Depreciation Amortization	1,295	1,337	1,246	406	1,415
Accounts receivable	N/A	-5	52	N/A	N/A
Other Working Capital	1,681	834	1,018	526	-1,449
Other Operating Activity	9,962	9,640	10,597	-252	2,405
Operating Cash Flow	$-4,581	$-4,389	$-3,028	$-1,802	$-4,669

Cash Flows From Investing Activities
PPE Investments	N/A	-36	N/A	N/A	N/A
Net Acquisitions	14	N/A	N/A	N/A	N/A
Purchase Of Investment	N/A	789	N/A	N/A	-100
Sale Of Investment	1,069	N/A	95	95	N/A
Investing Cash Flow	$1,083	$753	$95	$95	$-100

Cash Flows From Financing Activities
Change In Short Term Borrowing	500	200	N/A	N/A	N/A
Debt Repayment	N/A	N/A	N/A	N/A	-3,388
Common Stock Issued	476	476	150	N/A	2,858
Other Financing Activity	425	437	128	220	8,169
Financing Cash Flow	$1,401	$1,113	$278	$220	$7,639

Exchange Rate Effect	-9	1	0	0	1
Beginning Cash Position	2,658	2,856	2,856	2,856	77
End Cash Position	109	334	202	1,370	2,658
Net Cash Flow	$-2,549	$-2,522	$-2,655	$-1,487	$2,582

Free Cash Flow
Operating Cash Flow	-4,581	-4,389	-3,028	-1,802	-4,669
Capital Expenditure	N/A	-36	N/A	N/A	N/A
Free Cash Flow	-4,581	-4,425	-3,028	-1,802	-4,669